Skip to content
GLP1-US
Prices checked Wegovy pill $149 Wegovy pen $349 Zepbound $299–449 Foundayo from $149 Ozempic $349 Medicare Bridge $50 Compounded sema $175 All prices →

We may earn a commission when you click links to providers, and partner relationships can affect which providers we feature and their order. Advertiser Disclosure

ComparisonsWegovySaxenda

Saxenda vs Wegovy: 6.4% vs 15.8% Weight Loss in STEP 8

Saxenda vs Wegovy: daily liraglutide vs weekly semaglutide. STEP 8: 6.4% vs 15.8% weight loss. Saxenda ends Jan 2027. Prices as of Oct 2026.

Checked against primary sources such as FDA labels, CMS and provider pages
Updated
How we check facts →
Daily pen and weekly auto-injector with a row of day tiles
★ Editor's Choice
Chia Health logo

Chia Health

Our #1 pick for GLP-1 weight loss online

  • One monthly price: clinician, medication and free shipping included
  • Semaglutide or tirzepatide, as a weekly injection or a daily tablet
  • No insurance needed; HSA/FSA and Klarna accepted

Compounded medications, not FDA-approved. Prices checked Nov 17, 2026. Advertiser Disclosure

$212.89 first month, then $349/mo

6-month plan: $249/mo, paid upfront ($1,396.89 for the first 6 months). Microdose: $109.19 first month, then $179/mo.

Get Started Read our Chia Health review

Head-to-head trial: STEP 8, JAMA 2022

In the STEP 8 head-to-head trial, weekly Wegovy users lost 15.8% of body weight at 68 weeks vs 6.4% on daily Saxenda. Saxenda is being discontinued, with last shipments in late January 2027.

Saxenda: 1 shot a dayWegovy: 1 shot a week or 1 pill a daySaxenda ends Jan 2027Wegovy from $199 self-pay (as of Oct 2026)

We may earn a commission if you sign up through some links. Partner relationships can affect which providers we feature and their order; prices and medical facts are reported the same way for every provider.

STEP 8 · 68 weeks · 338 adults
MeasureSaxenda (liraglutide 3 mg daily)Wegovy (semaglutide 2.4 mg weekly)
Average weight loss6.4%15.8%
Lost 15% or more12.0%55.6%
Stopped for side effects12.6%3.2%
Shots per year36552
Average weight change in one open-label trial, JAMA 2022. Individual results vary.

”Novo Nordisk says it will discontinue Saxenda, with last shipments to wholesalers in late January 2027. The company says the decision is not the result of any safety or quality-related concerns.” Source: NovoCare Saxenda page, checked Oct 17, 2026.

01 At a glance

Saxenda vs Wegovy at a Glance

Both are Novo Nordisk GLP-1 drugs approved by the FDA for chronic weight management. The difference starts with the molecule: Saxenda is liraglutide, Wegovy is semaglutide. For the molecule-level view, see semaglutide vs liraglutide.

FeatureSaxendaWegovy
Active ingredientLiraglutideSemaglutide
How often1 injection a dayPen: 1 injection a week · Pill: 1 tablet a day
Target dose3 mg a dayPen: 2.4 mg a week (HD: up to 7.2 mg) · Pill: 25 mg a day
Approved ages for weightAdults; teens 12+ with body weight over 60 kg and obesityPen: adults and teens 12+ · Pill: adults only (not established in children)
Other approved usesWeight management onlyLower risk of heart attack, stroke and CV death in adults with heart disease; MASH with liver fibrosis (pen)
Manufacturer self-pay priceNonePen $199 for first 2 fills, then $349/mo; HD $399; pill $149 to $299
Medicare GLP-1 Bridge ($50/mo)Not includedIncluded, pen and pill
GenericYes, liraglutide (Hikma, Meitheal; Teva To Be Discontinued)None
StatusBeing discontinued, last shipments late Jan 2027Available

Prices as of Oct 2026, from NovoCare and CMS. They can change.

02 Results

Wegovy vs Saxenda: Which Works Better in the STEP 8 Head-to-Head

STEP 8 is the only trial that put the two drugs side by side. It ran 68 weeks at 19 US sites with 338 adults with overweight or obesity and no diabetes, published in JAMA in 2022 (Rubino et al.). It was open-label, so people knew whether they were on the weekly or the daily drug.

  • Wegovy (semaglutide 2.4 mg weekly)15.8%
  • Saxenda (liraglutide 3 mg daily)6.4%
  • Placebo (pooled)1.9%
STEP 8, average weight change at 68 weeks. Averages from one trial; individual results vary.
9.4 points
extra average loss with semaglutide vs liraglutide (95% CI 6.8 to 12.0)
70.9% vs 25.6%
lost 10% or more of body weight
55.6% vs 12.0%
lost 15% or more
38.5% vs 6.0%
lost 20% or more

For saxenda weight loss outside the head-to-head, the labels report their own trials. These used different people, lengths and designs, so do not line them up as a ranking:

  • Saxenda label, Study 1: 7.4% average loss vs 3.0% on placebo at 56 weeks.
  • Wegovy pen label, STEP 1: 14.9% vs 2.4% on placebo at 68 weeks.
  • Wegovy pill label, 25 mg: 13.6% vs 2.4% on placebo at 64 weeks.
  • Wegovy 7.2 mg label: 18.8% vs 15.5% on 2.4 mg at 72 weeks.

03 Dosing

Saxenda Dosing vs Wegovy Dosing: One Shot a Day vs One a Week

Saxenda is titrated weekly, Wegovy every 4 weeks (pen) or every 30 days (pill). That adds up to 365 injections a year on Saxenda vs 52 on the Wegovy pen. Your prescriber sets the dose.

Saxenda dosing schedule (label §2.2, Table 1)

WeekDaily dose
10.6 mg
21.2 mg
31.8 mg
42.4 mg
5 and on3 mg

Wegovy dosing (label §2.2 to 2.3)

StepPen, once weeklyPill, once daily
Start0.25 mg, weeks 1 to 41.5 mg, days 1 to 30
Escalation0.5 mg (wk 5 to 8), 1 mg (wk 9 to 12), 1.7 mg (wk 13 to 16)4 mg (days 31 to 60), 9 mg (days 61 to 90)
Maintenance2.4 mg from week 17 (or 1.7 mg); 7.2 mg optional after 4+ weeks on 2.4 mg25 mg from day 91

Label rules: for adults, 3 mg is the only maintenance dose, and Saxenda is stopped if 3 mg is not tolerated or if weight loss is under 4% at 16 weeks. Teens may drop to 2.4 mg, and stop if BMI has not fallen at least 1% after 12 weeks on maintenance. Missed a dose: take the next one as scheduled, no extra dose; after more than 3 days, restart at 0.6 mg.

Full step-by-step schedule: Wegovy dosage. Pill vs pen trade-offs: Wegovy pill vs injection.

04 Side effects

Saxenda Side Effects vs Wegovy Side Effects

Both drugs cause mostly stomach-related side effects, usually during dose increases. In STEP 8, gastrointestinal events were similar (84.1% on semaglutide, 82.7% on liraglutide), but fewer people stopped Wegovy because of side effects.

Saxenda (liraglutide)

  • Nausea in adult trials: 39.3% vs 13.8% on placebo (label §6.1)
  • STEP 8: 12.6% stopped for side effects
  • Extra label warning: heart rate increase, with heart rate checked at regular intervals

Wegovy (semaglutide)

  • Nausea in adult trials (2.4 mg): 44% vs 16% on placebo (label §6.1)
  • STEP 8: 3.2% stopped for side effects
  • Extra approved uses come with the same core warnings

Shared label warnings

Boxed warning for thyroid C-cell tumors (not for people with a personal or family history of medullary thyroid carcinoma or MEN 2)PancreatitisGallbladder diseaseAcute kidney injury from dehydrationSevere GI reactionsAspiration risk under anesthesia

In January 2026 the FDA asked for the suicidal-ideation warning to be removed from both labels after a review of 91 trials.

Tips for the queasy weeks: GLP-1 nausea guide. Semaglutide side effects in detail: Ozempic side effects.

05 Cost

Saxenda Cost vs Wegovy Cost in 2026

The biggest practical gap is price. Saxenda has no manufacturer self-pay program and its savings card closed to new enrollees on June 30, 2023. Wegovy has cash prices through NovoCare and a $50 Medicare option. Full breakdown of what Saxenda costs by pharmacy and plan: Saxenda cost.

OptionSaxendaWegovy
Manufacturer self-payNonePen: $199/mo for the first 2 fills (0.25 and 0.5 mg, new patients, through Dec 31, 2026), then $349/mo · HD 7.2 mg: $399/mo · Pill: $149 (1.5 mg), $199 (4 mg), $299 (9 and 25 mg)
With commercial insuranceSavings card closed to new enrollees (2023)Savings card: as little as $25/mo, max savings $100/mo
Medicare GLP-1 BridgeNot included$50/mo copay, Jul 1, 2026 to Dec 31, 2027, eligibility rules apply
List priceNot published by Novo on NovoCare$1,349.02 per pen box or pill bottle
From Jan 1, 2027DiscontinuedNovo list price cut to $675/mo
Generic liraglutideTeva has not published a priceNo generic

All prices as of Oct 2026 and subject to change. One 18 mg Saxenda or liraglutide pen lasts 6 days at 3 mg, so a 30-day supply at full dose is 5 pens; ask the pharmacy for its cash price on a 5-pen pack.

Go deeper: Wegovy cost, Medicare GLP-1 Bridge, Wegovy without insurance.

06 Generic

Is There a Generic Saxenda, and What Happens After January 2027?

Brand Saxenda leaving does not take liraglutide off the market. Generic liraglutide for weight management is FDA-approved and stays an option wherever a pharmacy stocks it, and asking “when will Saxenda be back in stock” no longer applies once brand shipments end.

  1. Dec 23, 2014 · FDA approves Saxenda (liraglutide 3 mg) for chronic weight management.

  2. Jun 30, 2023 · Saxenda savings card closes to new enrollees.

  3. Aug 28, 2025 · Teva announces FDA approval and launch of generic Saxenda, which it calls the first generic GLP-1 indicated for weight loss. No price published.

  4. Jan 13, 2026 · FDA requests removal of the suicidal-ideation warning from GLP-1 weight-loss labels, including Saxenda and Wegovy.

  5. Late Jan 2027 · Last brand Saxenda shipments to wholesalers, per Novo Nordisk.

Compounded liraglutide is also sold online (for example by Henry Meds at $179/mo as of Oct 2026), but compounded drugs are not FDA-approved and are not the same as Saxenda or generic liraglutide.

07 Switching

Switching From Saxenda to Wegovy

Neither label gives a Saxenda-to-Wegovy dose conversion. Both labels say not to combine them with another GLP-1 drug.

  1. 01

    Talk to your prescriber first. They decide when your last Saxenda dose is and when Wegovy starts.

  2. 02

    Start Wegovy at the bottom. The label starts everyone at 0.25 mg weekly (pen) or 1.5 mg daily (pill), even after liraglutide.

  3. 03

    Check coverage. A new drug often means a new prior authorization; without coverage, NovoCare self-pay is $199 for the first 2 fills.

  4. 04

    Plan around the date. If you are still on Saxenda, set up the switch before shipments end in late January 2027.

How to get the prescription: how to get Wegovy.

08 Who picks Saxenda

Who Might Still Pick Saxenda or Generic Liraglutide?

Coverage only for liraglutide.

Some plans list liraglutide but not semaglutide. Generic liraglutide keeps that route open after brand Saxenda ends.

Teens 12 and older.

Saxenda and the Wegovy pen are both approved for teens with obesity; a clinician may prefer one based on history and tolerability.

Stopped semaglutide for side effects.

Liraglutide is a different molecule with a shorter action. Whether it is worth a try is a clinician decision.

Also comparing tirzepatide: Saxenda vs Zepbound and Zepbound vs Wegovy.

09 FAQ

FAQ

Which is better, Saxenda or Wegovy?
In STEP 8, the only head-to-head trial, people on weekly Wegovy (semaglutide 2.4 mg) lost 15.8% of body weight on average at 68 weeks vs 6.4% on daily Saxenda (liraglutide 3 mg). Fewer stopped Wegovy for side effects (3.2% vs 12.6%). Which fits you still depends on your health history, coverage and your prescriber.
Is Saxenda being discontinued?
Yes. Novo Nordisk says it will discontinue Saxenda, with last shipments to wholesalers in late January 2027, and that the decision is not the result of any safety or quality-related concerns. Generic liraglutide is also sold by Hikma and Meitheal; the Teva generic launched in August 2025 is listed by FDA as To Be Discontinued (FDA posting of May 14, 2026).
Is there a generic Saxenda?
Yes. Teva announced FDA approval and launch of generic liraglutide (generic Saxenda) on August 28, 2025, calling it the first generic GLP-1 indicated for weight loss. It uses the same 3 mg daily dosing. Teva has not published a price, so check cash prices at your pharmacy for a 5-pen pack, which covers about 30 days at 3 mg.
Is Saxenda a GLP-1?
Yes. Saxenda (liraglutide) and Wegovy (semaglutide) are both GLP-1 receptor agonists made by Novo Nordisk. Saxenda was approved for weight management in December 2014 and is injected once a day; Wegovy is injected once a week or taken as a daily pill. Both labels advise against using them with any other GLP-1 drug.
Can you switch from Saxenda to Wegovy?
Yes, with your prescriber. There is no label conversion between the two. Wegovy starts at 0.25 mg weekly for 4 weeks (or a 1.5 mg pill for 30 days), and the labels advise against combining it with another GLP-1, so Saxenda stops before Wegovy starts. Your insurer may need a new prior authorization.
Is Saxenda cheaper than Wegovy?
Usually not. Saxenda has no manufacturer self-pay program, and its savings card closed to new enrollees on June 30, 2023. Wegovy costs $199 for the first 2 fills and then $349 a month through NovoCare, with the pill from $149, as of Oct 2026. Generic liraglutide pricing depends on the pharmacy.
Is Saxenda the same as Ozempic?
No. Ozempic is semaglutide for type 2 diabetes; Saxenda is liraglutide for weight management. The weight-loss version of semaglutide is Wegovy, which reached 15.8% average loss vs 6.4% for Saxenda in STEP 8.

More on Saxenda vs Ozempic and that pairing: Ozempic vs other GLP-1s.

Weekly instead of daily: check your Wegovy price

Sources

  1. Rubino DM et al. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial. JAMA. 2022;327(2):138-150. Checked 2026-10-17.
  2. Novo Nordisk / FDA. Saxenda (liraglutide) injection, Prescribing Information, Revised 02/2026 (§1, §2.1 to 2.2, §5.5, §6.1, §14, §16). Checked 2026-10-17.
  3. Novo Nordisk / FDA. Wegovy (semaglutide) injection and tablets, Prescribing Information, Revised 06/2026 (§1, §2.2 to 2.3, §6.1, §8.4, §14). Checked 2026-10-17.
  4. NovoCare. Saxenda: discontinuation notice and savings status. Checked 2026-10-17.
  5. NovoCare. Wegovy self-pay and savings. Checked 2026-10-16.
  6. CMS. Medicare GLP-1 Bridge: information for Part D plans. Checked 2026-10-16.
  7. Teva. FDA approval and launch of generic Saxenda (liraglutide injection), Aug 28, 2025. Checked 2026-10-17.
  8. FDA Drug Safety Communication. Removal of suicidal behavior and ideation warning from GLP-1 weight-loss labels, Jan 13, 2026. Checked 2026-10-16. Saxenda first approval Dec 23, 2014: Drugs@FDA NDA 206321 approval package.

Last updated October 17, 2026 · By the GLP1-US Editorial Team

Chia Health: Chia Health sells compounded GLP-1 plans with medication included: semaglutide $212.89 the first month, then $349 a month, or $249 a month on a 6-month plan paid upfront. Not FDA-approved; no insurance needed.

Get Started
Medical Disclaimer

This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a licensed physician or qualified health provider with any questions about a medical condition or medication. Never disregard professional medical advice or delay seeking it because of something you have read on this website.

Ready to see if a GLP-1 is right for you?

Compare our top 5 providers and find the lowest price for your situation in under 5 minutes.

References

  1. FDA: Drug Approvals and Databases, U.S. Food & Drug Administration, 2024
  2. NIH: National Library of Medicine, PubMed, 2024
  3. Wegovy (semaglutide) Prescribing Information, Novo Nordisk, 2026
  4. Ozempic (semaglutide) Prescribing Information, Novo Nordisk, 2026